New findings by researchers at Cardiff University suggest that intensive therapy during the early stages of multiple sclerosis (MS) leads to better long-term outcomes for patients, despite it often being viewed as a riskier option than other first-line treatments.
The MS Trust has teamed up with a group of experienced health professionals to develop guidelines to support discussions between health professionals and people with multiple sclerosis (MS) regarding pregnancy.
Britain’s cystic fibrosis (CF) sufferers have received fresh hope of receiving a life-saving drug after officials agreed to sit down together to try and end a funding deadlock.
Experts are calling for more research to be conducted into the link between Motor Neurone Disease (MND) and top-level sport after the results of a recent study.
A new study has found a method which could restore muscle strength in those suffering from Duchenne muscular dystrophy (DMD).
Scientists have taken a step closer to being able to provide a ‘new voice’ for people who are unable to verbally communicate, such as those living with amyotrophic lateral sclerosis (ALS) or recovering from strokes.
A recent retrospective meta-analysis has found that Pseudomonas aeruginosa (P. aeruginosa) – a bacterium that can cause impaired lung function – may be the cause for more serious forms of cystic fibrosis (CF).
New research has offered fresh insights into the types of cells found in the brains of people with multiple sclerosis (MS), which could help develop improved therapies.
The exact cause of multiple sclerosis (MS) remains a mystery. We do, however, know that it is an autoimmune disease that attacks myelin – the protective coating of nerve cells – which eventually leads to the death of those nerve…
According to a study of medical records, people with relapsing-remitting multiple sclerosis (MS) who begin early treatment with a disease-modifying drug have a lower risk of developing secondary progressive MS.